Literature DB >> 15154780

Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points.

Suzanne Sirois1, Dong-Qing Wei, Qishi Du, Kuo-Chen Chou.   

Abstract

Pharmacophore modeling can provide valuable insight into ligand-receptor interactions. It can also be used in 3D (dimensional) database searching for potentially finding biologically active compounds and providing new research ideas and directions for drug-discovery projects. To stimulate the structure-based drug design against SARS (severe acute respiratory syndrome), a pharmacophore search was conducted over 3.6 millions of compounds based on the atomic coordinates of the complex obtained by docking KZ7088 (a derivative of AG7088) to SARS CoV M(pro) (coronavirus main proteinase), as reportedly recently (Chou, K. C.; Wei, D. Q.; Zhong, W. Z. Biochem. Biophys. Res. Commun. 2003, 308, 148-151). It has been found that, of the 3.6 millions of compounds screened, 0.07% are with the score satisfying five of the six pharmacophore points. Moreover, each of the hit compounds has been evaluated for druggability according to 13 metrics based on physical, chemical, and structural properties. Of the 0.07% compounds thus retrieved, 17% have a perfect score of 1.0; while 23% with one druggable rule violation, 13% two violations, and 47% more than two violations. If the criterion for druggability is set at a maximum allowance of two rule violations, we obtain that only about 0.03% of the compounds screened are worthy of further tests by experiments. These findings will significantly narrow down the search scope for potential compounds, saving substantial time and money. Finally, the featured templates derived from the current study will also be very useful for guiding the design and synthesis of effective drugs for SARS therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154780     DOI: 10.1021/ci034270n

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  37 in total

1.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

2.  Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.

Authors:  Christopher M Coleman; Jeanne M Sisk; Rebecca M Mingo; Elizabeth A Nelson; Judith M White; Matthew B Frieman
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

3.  Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models.

Authors:  Guo Li; Kendra M Haney; Glen E Kellogg; Yan Zhang
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

4.  Predicting biological functions of compounds based on chemical-chemical interactions.

Authors:  Le-Le Hu; Chen Chen; Tao Huang; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

5.  3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors.

Authors:  Mahreen Arooj; Sundarapandian Thangapandian; Shalini John; Swan Hwang; Jong Keun Park; Keun Woo Lee
Journal:  Int J Mol Sci       Date:  2011-12-12       Impact factor: 5.923

6.  Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method.

Authors:  Xiao-Bo Li; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.

Authors:  Ying Ma; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

8.  Protein domain boundary predictions: a structural biology perspective.

Authors:  Svetlana Kirillova; Suresh Kumar; Oliviero Carugo
Journal:  Open Biochem J       Date:  2009-01-21

9.  An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease.

Authors:  Tianhua Zhai; Fangyuan Zhang; Shozeb Haider; Daniel Kraut; Zuyi Huang
Journal:  Front Mol Biosci       Date:  2021-05-17

10.  Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Authors:  Lei Liu; Ying Ma; Run-Ling Wang; Wei-Ren Xu; Shu-Qing Wang; Kuo-Chen Chou
Journal:  Drug Des Devel Ther       Date:  2013-04-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.